Skip to Main Content

Paper Details

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection.
Onco Targets Ther
11
2021
Author NameAffiliation
Edwin M PosadasSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Dolores Di VizioSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Leigh EllisSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Michael R FreemanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Stephen J FreedlandSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Stephen J FreedlandDurham VA Medical Center
  • 1 - 6

Datasets

Release 1.2